Universität zu Köln

Galle, P. R., Kim, R. D., Sung, M. W., Harris, W. P., Waldschmidt, D., Cabrera, R., Mueller, U., Nakajima, K., Ishida, T. and El-Khoueiry, A. B. (2020). Updated results of a phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Ann. Oncol., 31. S. S691 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Galle, P. R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kim, R. D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Sung, M. W. UNSPECIFIED UNSPECIFIED UNSPECIFIED Harris, W. P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Waldschmidt, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Cabrera, R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Mueller, U. UNSPECIFIED UNSPECIFIED UNSPECIFIED Nakajima, K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ishida, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED El-Khoueiry, A. B. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-320661
DOI:	10.1016/j.annonc.2020.08.1106
Journal or Publication Title:	Ann. Oncol.
Volume:	31
Page Range:	S. S691 - 2
Date:	2020
Publisher:	ELSEVIER
Place of Publication:	AMSTERDAM
ISSN:	1569-8041
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/32066